Lack of efficacy of single-dose prednisolone in moderately severe asthma.
To assess the effectiveness of single-dose prednisolone in reducing the length of illness and hospital stay in children admitted with moderately severe asthma. A randomised, double-blind, controlled trial of a single dose of prednisolone in 64 children presenting with an acute attack of asthma with arterial oxygen saturation less than 93%. No significant differences in the rate of recovery of oxygen saturation, lung function measurements or duration of hospital stay were found. This study failed to confirm the benefit of a single dose of prednisolone in the management of children with acute severe asthma.